Laurent Audoly

PriveBio is a precision medicine biotech focused on developing first-in-class therapeutics targeting metabolic dysfunction and fibro-inflammation in cardiorenal metabolic diseases (obesity, heart failure, NASH/MASH, and chronic kidney diseases), prosecuting validated targets from human proteo-genomics data across very large human datasets.